Showing results (11-20 of 167) with videos related to

Sort By:
Pageof 17
La Radiologia Medica|November 1, 1992
[The proton radiotherapy of melanoma of the uvea. The technic, methodology and first clinical observations]V Vitale, T Scolaro, L Andreucci, et al.
La Radiologia Medica|October 1, 1989
[Fractionated and hyperfractionated total body irradiation in the conditioning of allogenic bone marrow transplant in acute lymphatic leukemia. Results]R Corvò, F Frassoni, P Franzone, et al.
Cancer Nursing|October 1, 1993
Management of acute radiodermatitis. Pharmacological or nonpharmacological remedies?D Dini, R Macchia, A Gozza, et al.
Gynecologic Oncology|September 1, 1990
Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second lookM Bruzzone, L Repetto, S Chiara, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 1, 1991
Abdominopelvic radiotherapy following surgery and chemotherapy in advanced ovarian cancerS Chiara, M Orsatti, P Franzone, et al.
American Journal of Clinical Oncology|August 1, 1994
Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma. GONO (North-West Oncologic Cooperative Group)S Chiara, M Bruzzone, L Merlini, et al.
Anticancer Research|March 1, 1991
Alternating chemotherapy with cyclophosphamide, doxorubicin, vincristine and cisplatin, etoposide followed by prophylactic cranial and thoracic irradiation for small cell lung cancer (SCLC): long-term resultsA Ardizzoni, V Fusco, C Pennucci, et al.
Chirurgia Italiana|January 1, 1995
[Locally advanced non-small cell lung tumors: curative or palliative radiotherapy]D Scarpati, T Scolaro
The Cancer Journal From Scientific American|July 1, 1997
Predictive factors for outcome in invasive bladder cancer treated with alternating chemoradiotherapyG Sanguineti, M Orsatti, M P Sormani, et al.
British Journal of Cancer|September 25, 1999
Induction chemotherapy followed by concurrent standard radiotherapy and daily low-dose cisplatin in locally advanced non-small-cell lung cancerA Ardizzoni, F Grossi, T Scolaro, et al.
Pageof 17